Inside this issue
• Preliminary study results from the COVIDEPI study
• Updates from the Coronavirus Immune Therapy (COVIDIT) Study launch
• How to breathe during a pandemic: implications of COVID-19 for people with chronic lung disease
Word from the editors
Although the world has had several pandemics in the past centaury, COVID-19 stands out because of its transmissibility and the impact it has had on daily living conditions of people globally, ’the new normal.’
As researchers around the world investigate existing products and develop news ones for the prevention and/or treatment of COVID-19, we share details on two studies at MLI (COVIDEPI and COVIDIT) and give advice to patients suffering from chronic lung diseases during this pandemic.
This quarterly newsletter is available on MLI’s website: mli.mak.ac.ug. Subscribe for this newsletter by emailing news@mli.mak.ac.ug with ‘Subscribe’ in the subject. For any comments or questions please reach out to the editorial team.
Editorial Team
Health Economist STREAM trial
jjnidoi@gmail.com
Respiratory Technician MLI clinic
paundagi@gmail.com
Co-investigator Exit-TB
simonwalusimbi@gmail.com